2000•Europe PMC (PubMed Central)Open access

Freebies to MDs targeted as drug industry starts publicizing CME fines

Patrick Sullivan

Open full text 0 citations

Abstract

Canada‚s drug companies are now getting their knuckles rapped publicly if they violate industry rules concerning the CME events they sponsor. Several rulings made by the Marketing Practices Review Committee of Canada‚s Research-Based Pharmaceutical Companies (Rx&D, formerly the Pharmaceutical

About this research paper

What this paper is about

Canada‚s drug companies are now getting their knuckles rapped publicly if they violate industry rules concerning the CME events they sponsor. Several rulings made by the Marketing Practices Review Committee of Canada‚s Research-Based Pharmaceutical Companies (Rx&D, formerly the Pharmaceutical

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Canada‚s drug companies are now getting their knuckles rapped publicly if they violate industry rules concerning the CME events they sponsor. Several rulings made by the Marketing Practices Review Committee of Canada‚s Research-Based Pharmaceutical Companies (Rx&D, formerly the Pharmaceutical

Key concepts: Drug industry, Pharmaceutical industry, Drug approval, Business, Drug, Medicine, Pharmacology, Engineering

Related papers

Back to paper searchBrowse research topicsOriginal source
Freebies to MDs targeted as drug industry starts publicizing CME fines — Research Paper | ScholarLens